Nanxin Pharmaceuticals: has repurchased 142,100 shares with a total funds amount of 1.0038 million yuan.

Nanxin Pharmaceuticals announced that the company repurchased 142,100 shares for the first time through centralized bidding trading on May 30, 2025, accounting for 0.05% of the company's total share capital of 274 million shares. The repurchase price ranged from 7.02 yuan/share to 7.11 yuan/share, with a total fund used of 1.0038 million yuan. This repurchase complies with relevant laws and regulations and the company's repurchase plan requirements, with the aim of implementing equity incentives or employee shareholding plans.